About: IP waiver

Coronavirus 04-05-2022

Widely criticised IP waiver text to be presented to all WTO members

A widely criticised document produced in international negotiations is set to be presented to all 164 World Trade Organisation (WTO) members in the next step of talks on a waiver on intellectual property (IP) rights for COVID-19 vaccines and treatments.
Health 22-04-2022

Industry disputes claims that waiving IP rights will ensure availability of medicines

The European Commission is leading talks on a waiver of intellectual property (IP) rights on COVID vaccines and treatments. However, critics from the pharmaceutical industry argue that changes to the current IP system could jeopardise research and development in their sector.
Health 14-04-2022

EU defends IP waiver compromise amid pressure on India, South Africa to reject it

A broad international platform of activists, unions and experts has urged India and South Africa to reject the leaked compromise on intellectual property rights on COVID-19 vaccines, which the European Commission considers the ‘most promising path’ to sort out the issue.
Coronavirus 17-03-2022

New challenges ahead as provisional compromise on IP waivers is reached in WTO

News of a provisional compromise to waive intellectual property rights for COVID-19 vaccines between the EU, USA, India and South Africa in the World Trade Organisation (WTO), leaves out treatments for COVID-19.
Health 19-02-2022

EU-AU summit makes big health promises, but not on IP waivers

EU and African leaders laid out a number of promises to secure equitable access to vaccines at the end of a two-day summit in Brussels on Friday (18 February). No decision on lifting intellectual property rights was reached, however.
Coronavirus 21-01-2022

Macron emphasises technology transfer in fight against vaccine shortages

French President Emmanuel Macron proposed pressuring pharmaceutical companies to share their knowledge to fight vaccine shortages worldwide, as an alternative to waiving intellectual property (IP) rights. 
05-11-2021

Global vaccine access remains wanting amid leaders’ commitments

Despite tentative steps to bring vaccine production to poorer countries and generic commitments from world leaders, global access to the COVID-19 vaccine is still far from equal.
Coronavirus 28-10-2021

EU’s alternative to IP waiver won’t speed up vaccination in poorer countries: health expert

The EU’s counter-proposal to the request to waive intellectual property (IP) rights on COVID vaccines is meaningless as it deals with patents without any technology transfer, according to a health expert.
Coronavirus 21-10-2021

Vaccine waiver battle rumbles into EU–African Union summit

EU and African officials are still at loggerheads over whether to waive intellectual property protection for COVID vaccines ahead of a meeting between EU and African Union foreign ministers meet in Rwanda next week.
Special ReportOpinionPromoted content
Health 10-06-2021

G7 & EU Must Put Lives before Profits and ‘Vaccinate Our World’ Now!

After more than a year blanketed by the pandemic—communities, economies, and health systems in the European Union and beyond continue to be devastated. It is all too clear that the world is in desperate need of an immediate and novel...
Health 10-06-2021

We need to prepare the world for the next health crisis now – MEP

The world needs to rethink intellectual property rights to get ready for the next pandemic and Europe has to do its part as a constructive partner at the negotiating table, Belgian socialist MEP Kathleen Van Brempt told EURACTIV in an interview.
Coronavirus 10-06-2021

MEPs vow to waive COVID vaccine patents amid Commission’s resistance

The European Parliament endorsed a resolution on Wednesday (9 June) calling for a temporary waiver of COVID-19 vaccine patents, while the Commission remained firm in its opposition to such measures and said it has different plans to speed up the global vaccine rollout.
Coronavirus 04-06-2021

EU proposes alternative to IP waiver to expand global vaccine access

The EU has set out its plan to boost deliveries of COVID-19 vaccines to developing countries, which banks on open supply chains, encouraging production and compulsory licences rather than an IP waiver. 
Coronavirus 04-06-2021

Waiving vaccine patents saves lives, health campaigners tell the EU

A series of protests have been staged in front of the European Commission and at a vaccine manufacturing plant in Belgium, calling for temporarily lifting of the intellectual property (IP) rights of COVID-19 vaccines and treatments.
Health 04-06-2021

Reshaping global health after COVID-19

Download PDF  

The COVID-19 pandemic has cast a new light on the compelling necessity of addressing health inequalities across the globe.
Coronavirus 21-05-2021

If we forcibly remove patents on vaccines, we are killing a golden industry

Instead of being sidetracked by the debate on waiving patents on COVID vaccines, the EU must come up with a new pharma strategy and strengthen its pharmaceutical industry, writes Pernille Weiss.
Coronavirus 20-05-2021

Commission set to propose alternatives to COVID vaccine IP waiver

As the debate on waiving intellectual property (IP) rights on COVID vaccines heats up, the European Commission is working on an alternative proposal that it wants to submit to the World Trade Organisation, while EU lawmakers remain split on the subject.
Coronavirus 30-04-2021

MEPs vote down call for COVID vaccine IP waiver

An amendment calling on the EU to back India and South Africa's proposal to temporary lift intellectual property rights for the COVID-19 vaccine was rejected by the European Parliament on Thursday (29 April).
Coronavirus 27-04-2021

Commission, industry dubious about IP rights waiver for COVID-19 vaccines

Both the European Commission and vaccine manufacturers are not convinced by the potential benefits of waiving the intellectual property (IP) rights of COVID-19 vaccines and treatments.